Centre mulls bulk drug policy

The Centre intends to revive the country’s active pharmaceutical ingredient (API) or bulk drug market by formulating a separate policy, which will promote the industry internationally, apart from catering to domestic requirement.

The Department of Pharmaceuticals (DoP) will soon hold discussions with various stakeholders to prepare a White Paper for the policy, a senior government official said.

“Formulating the draft API policy is a priority for DoP and the work in that direction has already started,” the official told Business Standard, indicating the first draft of the policy may be part of the new government’s 100-day agenda.


Source : http://www.business-standard.com/article/economy-policy/centre-mulls-bulk-drug-policy-114063000056_1.html


Tagged as:

Categorised in: Chemical, Pharma & Healthcare, Sector News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: